促销时间表 Turnstone Biologics Corp. Common Stock
先进的时间表
简单图表
关于公司 Turnstone Biologics Corp. Common Stock
Turnstone Biologics Corp., a clinical stage biotechnology company, focuses on developing medicines to treat and cure patients with solid tumors. The company's lead product includes TIDAL-01 that is in Phase 1 clinical trials for the treatment of breast cancer, colorectal cancer, head and neck cancer and uveal melanoma, as well as an investigator sponsored trials to treat colorectal cancer, head and neck cancer, and cutaneous and non-cutaneous melanomas. It is also developing TIDAL-02, which is in preclinical development for the treatment of solid tumors. 更多详情| IPO date | 2023-07-21 |
|---|---|
| ISIN | US90042W1009 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://turnstonebio.com |
| Цена ао | 2.68 |
| 每日价格变化: | +5.35% (0.48) |
|---|---|
| 每周价格变化: | +2.97% (0.4911) |
| 每月价格变化: | +0.1386% (0.505) |
| 3个月内价格变化: | -8.55% (0.553) |
| 六个月内的价格变化: | -78.11% (2.31) |
| 每年价格变化: | -80.13% (2.545) |
| 3年内价格变化: | 0% (0.5057) |
| 5年内价格变化: | 0% (0.5057) |
| 10年价格变化: | 0% (0.5057) |
| 年初以来价格变化: | +2.99% (0.491) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Orbimed Advisors LLC. | 3099265 | 13.42 |
| FMR, LLC | 2546661 | 11.02 |
| Bank of America Corporation | 914058 | 3.96 |
| Point72 Asset Management, L.P. | 833333 | 3.61 |
| Eventide Asset Management LLC | 708317 | 3.07 |
| Citadel Advisors Llc | 688468 | 2.98 |
| PFM Health Sciences, LP | 633313 | 2.74 |
| 72 Investment Holdings, LLC | 549981 | 2.38 |
| Sectoral Asset Management, Inc. | 517648 | 2.24 |
| Blackrock Inc. | 301925 | 1.31 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.00268 | 17.09 | 1.54048 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Dr. Sammy J. Farah M.B.A., Ph.D. | President, CEO & Director | 678.51k | 1973 (52 年) |
| Dr. Venkat Ramanan Ph.D. | Chief Financial Officer | 346.13k | 1970 (55 年) |
| Dr. Michael F. Burgess M.D., MBChB, Ph.D. | Interim Chief Medical Officer & Executive Director | 212.69k | 1963 (62 年) |
| Ms. Saryah Azmat | Chief Business Officer | 479.73k | 1990 (35 年) |
| Dr. Vijay Chiruvolu M.B.A., Ph.D. | Interim Chief Technology Officer | N/A | 1962 (63 年) |
| Dr. David Stojdl Ph.D. | Senior Vice President of Research & Discovery | ||
| Dr. Ines Verdon M.D. | Senior Vice President of Clinical Development |
地址: United States, LA Jolla. CA, 9310 Athena Circle - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://turnstonebio.com
网站: https://turnstonebio.com
